We are live on ! Find out more
ECM

Estabrook Capital Management Portfolio holdings

AUM $685M
1-Year Est. Return 26.64%
This Fund
S&P 500
This Quarter Est. Return
+0.15%
1 Year Est. Return
+26.64%
3 Year Est. Return
+76.16%
5 Year Est. Return
+96.13%
10 Year Est. Return
+311.62%
AUM
$619M
AUM Growth
-$29.6M
Cap. Flow
-$24.3M
Cap. Flow %
-3.93%
Top 10 Hldgs %
43.74%
Holding
349
New
1
Increased
34
Reduced
104
Closed
19

Top Buys

Rank Stock Value
1
NKE icon
Nike
NKE
+$464K
2
PEP icon
PepsiCo
PEP
+$214K
3
PFE icon
Pfizer
PFE
+$138K
4
BA icon
Boeing
BA
+$101K
5
SLB icon
SLB Ltd
SLB
+$99.7K

Top Sells

Rank Stock Value
1
COST icon
Costco
COST
+$2.71M
2
JPM icon
JPMorgan Chase
JPM
+$2.54M
3
AAPL icon
Apple
AAPL
+$2.46M
4
MSFT icon
Microsoft
MSFT
+$1.83M
5
UNP icon
Union Pacific
UNP
+$1M

Sector Composition

Rank Sector Weight
1 Technology 25.15%
2 Financials 20.44%
3 Industrials 12.9%
4 Healthcare 11.37%
5 Energy 9.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MLM icon
176
Martin Marietta Materials
MLM
$33.3B
$39.2K 0.01%
82
TM icon
177
Toyota
TM
$225B
$38.8K 0.01%
220
CODI icon
178
Compass Diversified
CODI
$926M
$38.3K 0.01%
2,050
ADP icon
179
Automatic Data Processing
ADP
$108B
$38.2K 0.01%
125
GM icon
180
General Motors
GM
$78.1B
$37.8K 0.01%
803
BMEZ icon
181
BlackRock Health Sciences Trust II
BMEZ
$1.01B
$37.1K 0.01%
2,491
+83
+3% +$1.3K
HTGC icon
182
Hercules Capital
HTGC
$3.14B
$36.8K 0.01%
1,918
+40
+2% +$808
ARCC icon
183
Ares Capital
ARCC
$14.3B
$36.6K 0.01%
1,650
NFLX icon
184
Netflix
NFLX
$318B
$35.4K 0.01%
380
AZN icon
185
AstraZeneca
AZN
$250B
$34.9K 0.01%
238
PEG icon
186
Public Service Enterprise Group
PEG
$37.2B
$33.7K 0.01%
410
VRTX icon
187
Vertex Pharmaceuticals
VRTX
$134B
$33.5K 0.01%
69
NFG icon
188
National Fuel Gas
NFG
$7.72B
$32.8K 0.01%
414
SNY icon
189
Sanofi
SNY
$105B
$32.4K 0.01%
585
-72
-11% -$3.9K
NTR icon
190
Nutrien
NTR
$31.9B
$32.3K 0.01%
650
PNW icon
191
Pinnacle West Capital
PNW
$12B
$31.1K 0.01%
326
MS.PRA icon
192
Morgan Stanley Series A Preferred Stock
MS.PRA
$770M
$30.9K 0.01%
1,355
-1,350
-50% -$32.1K
KLAC icon
193
KLA
KLAC
$264B
$29.9K ﹤0.01%
440
C.PRN icon
194
Citigroup Capital XIII 7.875% Fixed Rate/Floating Rate Trust Preferred Securities
C.PRN
$2.35B
$29.9K ﹤0.01%
1,000
-450
-31% -$13.7K
CLX icon
195
Clorox
CLX
$13.1B
$27.2K ﹤0.01%
185
WY icon
196
Weyerhaeuser
WY
$18.3B
$24.9K ﹤0.01%
850
GS.PRC icon
197
Goldman Sachs Group Inc Series C Preferred Stock
GS.PRC
$153M
$23.9K ﹤0.01%
1,048
SJM icon
198
J.M. Smucker
SJM
$12.7B
$23.7K ﹤0.01%
200
MS icon
199
Morgan Stanley
MS
$338B
$23.3K ﹤0.01%
200
PGNY icon
200
Progyny
PGNY
$2.12B
$22.3K ﹤0.01%
1,000

Similar funds

Estabrook Capital Management's Q1 2025 Portfolio in Review

As of Q1 2025, Estabrook Capital Management held 349 positions worth $619M, down 4.6% from $649M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Estabrook Capital Management withdrew a net $24.3M in Q1 2025, closing 19 positions and reducing 104 holdings. Its most notable exit was CVS Health, an estimated $843K position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 27% a quarter earlier, followed by Financials and Industrials.

Against the trend, Estabrook Capital Management opened a new position in Millrose Properties Inc worth $292.

  • Estabrook Capital Management's largest Q1 2025 buy was Millrose Properties Inc: 11 shares worth $292.
  • Estabrook Capital Management added most to Nike in Q1 2025, an estimated $464K increase.
  • Estabrook Capital Management's biggest Q1 2025 reduction was Costco, cutting an estimated $2.71M.
  • Estabrook Capital Management fully exited CVS Health in Q1 2025, selling an estimated $843K.
  • Estabrook Capital Management's ten largest holdings make up 44% of its $619M portfolio in Q1 2025.
  • Estabrook Capital Management opened 1 new position and closed 19 in Q1 2025.
  • Estabrook Capital Management's portfolio value fell 4.6% quarter-over-quarter to $619M.

Based on Estabrook Capital Management's 13F filing for Q1 2025, filed 14 May 2025.